Help Shape Federal Diabetes Prevention and Treatment Programs — Submit Your Comments!
Interested in diabetes prevention and treatment? The National Clinical Care Commission is seeking written comments about federal diabetes prevention and treatment programs. The public comment period is open from January 15, 2020 through March 31, 2020. Learn more about the questions available for comment and how to submit your comments.
The National Clinical Care Commission (“the Commission” or “NCCC”) evaluates and provides recommendations on the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States, including complications due to such diseases.
The Secretary of Health and Human Services approved the NCCC charter [PDF - 1.5 MB] on April 3, 2018. The Assistant Secretary for Health (ASH) provides guidance and oversight for the Commission’s function and activities. The Office of Disease Prevention and Health Promotion (ODPHP) will provide management and support services for the Commission’s activities.
The NCCC will conduct activities over the next 3 years, until October 2021. Learn about the Charge to the National Clinical Care Commission.